Streetbeat News

Products Services

META

PLTR

Palantir Technologies co-founder Peter Thiel emphasized the critical role of founders in the success of their companies, using Meta Platforms CEO Mark Zuckerberg as an example. Thiel highlighted Zuckerberg's decision to reject a $1 billion acquisition offer from Yahoo in 2006, arguing that a professional CEO would have likely accepted the offer. Thiel's comments underscore the unique vision and dedication founders bring to their companies.

Portfolio Pulse from Ananya Gairola

July 02, 2024 | 11:14 am

GILT

Gilat Satellite Networks' US-based subsidiary, DataPath, has secured over $9 million in orders to support the Department of Defense and other agencies, leading to a rise in Gilat's share price.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:13 am

HUMA

Humacyte shares are rising after the company received Regenerative Medicine Advanced Therapy designation from the FDA for treating advanced peripheral artery disease.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:11 am

TRAK

ReposiTrak has expanded its Food Traceability Network by adding 25 new produce suppliers. This move aims to enhance food safety and supply chain transparency.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:11 am

CKPT

Checkpoint Therapeutics has resubmitted its Biologics License Application (BLA) for cosibelimab to the FDA for the treatment of advanced skin cancer. The resubmission addresses issues raised in a previous complete response letter, which were related to manufacturing and not clinical data. The BLA is supported by positive safety and efficacy results from pivotal studies.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:11 am

CTSO

CytoSorbents has secured a $20M credit facility from Avenue Capital Group to support its CytoSorb® franchise, FDA and Health Canada applications for DrugSorb™-ATR, and refinance existing debt.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:10 am

KRMD

KORU Medical Systems has received regulatory clearance for its FreedomEdge Infusion System in Japan, potentially opening up a new market for the company's products.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:09 am

EVGN

Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN), is expanding its bio-inoculant product, Yalos™, to the winter wheat market, effectively doubling its potential reach. This expansion follows successful trials and aims to enhance crop productivity and sustainability. Lavie Bio also plans to expand Yalos™ to other key crops like soybean and canola by 2025.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:09 am

GRMN

Garmin (NYSE:GRMN) has secured a 5-year exclusive deal as the sole electronics and audio supplier for Independent Boat Builders, Inc. (IBBI), starting from model year 2025 through 2029. This agreement strengthens Garmin's long-standing relationship with IBBI, which builds over 25% of all boats sold in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:07 am

GILT

Gilat Satellite Networks' US-based subsidiary, DataPath, has received over $9 million in orders to support the US Department of Defense and other global agencies in field service and technology service programs.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:07 am